Sense and sensitivity: FOXO and ROS in cancer development and treatment

Stephen S Myatt1, Jan J Brosens, Eric W-F Lam

  • 1Cancer Research-UK Labs, Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, England, United Kingdom.

Insights

Forkhead box O (FOXO) transcription factors link longevity and cancer by regulating oxidative stress. Targeting the reactive oxygen species (ROS)-FOXO pathway offers new strategies against cancer and drug resistance.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Biology

Background:

  • Forkhead box O (FOXO) transcription factors are crucial regulators of cellular processes including longevity, cell fate, and tumor development.
  • The activity of FOXO is intricately linked to oxidative stress, particularly the production and signaling of reactive oxygen species (ROS).
  • Dysregulation in the coupling of ROS production, oxidative stress signaling, and FOXO activity is a key event in cancer initiation and progression.

Purpose of the Study:

  • To elucidate the central role of the FOXO transcription factor family in the context of oxidative stress and its implications for cancer.
  • To highlight the significance of the ROS-FOXO pathway as a therapeutic target in cancer treatment.
  • To explore how understanding the FOXO-ROS relationship can lead to novel cancer therapies that overcome drug resistance.

Main Methods:

  • The study integrates existing research on FOXO transcription factors and oxidative stress.
  • It analyzes the molecular mechanisms connecting reactive oxygen species (ROS) signaling with FOXO activity.
  • The focus is on the role of this pathway in cancer development, progression, and response to chemotherapy.

Main Results:

  • FOXO factors are pivotal in mediating cellular responses to oxidative stress, influencing both normal cellular functions and tumorigenesis.
  • The reactive oxygen species (ROS)-FOXO pathway is implicated in the cellular response to chemotherapy and is a significant contributor to drug resistance.
  • The reciprocal regulation between FOXO and ROS is a critical determinant of cancer cell survival and proliferation.

Conclusions:

  • The FOXO transcription factor family plays a central role in linking oxidative stress to cell fate and cancer.
  • Targeting the ROS-FOXO pathway presents a promising therapeutic strategy for overcoming resistance to conventional cytotoxic chemotherapy.
  • Further unraveling the intricate relationship between FOXO and ROS can pave the way for developing more effective anticancer treatments.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...